Physician profile
Jared Raabe
NPI 1710514377
$949.92
in general payments reported to CMS, 2019-2025
8 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $279 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Travel and Lodging: $65.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.00 |
| Travel and Lodging | $65.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $390.80 | 2024-2025 | Photrexa Viscous and Photrexa, Photrexa |
| Alcon Vision LLC | $211.30 | 2025 | Unity, Clareon |
| Dompe US, INC. | $203.45 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $33.62 | 2024 | Vevye |
| Tarsus Pharmaceuticals, INC. | $33.62 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $33.40 | 2024 | Acthar |
| Apellis Pharmaceuticals, INC. | $27.66 | 2025 | Syfovre |
| Bausch & Lomb Americas INC. | $16.07 | 2025 | Miebo, Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Raabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.